Abstract

CLC Number:

R994.11

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2016/V13/I10/630

[1] 唐莲, 周黎, 虞燕霞, 等. 126例丙戊酸钠血药浓度未达标病例的临床分析[J]. 中国药学杂志, 2012, 47(24): 2040-2042.
[2] Naranjo C A, Busto U, Sellers E M, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther,1981, 30(2): 239-245.
[3] Chu X M, Zhang L F, Wang G J, et al. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients[J]. Eur J Clin Pharmacol, 2012, 68(10): 1395-1401.
[4] 陈刚. 治疗药物监测理论与实践[M]. 北京: 人民军医出版社, 1988:385-409.
[5] 李铮燃, 朱乐亭, 高晨, 等. 248例脑肿瘤患者围手术期应用丙戊酸钠血药浓度监测分析[J]. 中国药物警戒, 2013,10(9): 520-522.
[6] Gu J, Huang Y. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient [J]. Am J Geriatr Pharmacother, 2009, 7(1): 26-33.
[7] Spriet I, Goyens J, Meersseman W, et al. Interaction between valproate and meropenem: a retrospective study [J]. Ann Pharmacother.2007, 41(7):1130-1136.
[8] Haroutiunian S, Ratz Y, Rabinovich B, et al. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study [J]. J Clin Pharmacol, 2009, 49(11): 1363-1369.
[9] 李爽, 李新林, 周敬凯, 等. 不同碳青霉烯类抗生素对丙戊酸血浆药物浓度的影响[J]. 中国感染与化疗杂志, 2015, 15(4):
387-390.
[10] Park M K, Lim K S, Kim T E, et al. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases[J]. Ther Drug Moni, 2012, 34(5):599-603.
[11] Mancl E E, Gidal B E. The effect of carbapenem antibiotics on plasma concentrations of valproic acid [J]. Ann Pharmacother, 2009, 43(12): 2082-2087.
[12] Ogawa K, Yumoto R, Hamada N, et al. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes[J]. Epilepsy Res, 2006,71(1): 76-87.
[13] Suzuki E, Nakai D, Ikenaga H, et al. In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs[J]. Xenobiotica, 2016, 46(2):126-131.
[14] 刘晓东, 刘美, 孙浩, 等. 碳青霉烯类抗菌药与丙戊酸相互作用的临床病例调查[J]. 中国新药杂志, 2015, 24(5): 595-600.
[15] 卜跃华. 碳青霉烯类抗生素与丙戊酸的相互作用[J]. 中国临床药理学杂志, 2013, 29(6): 469-470.
[16] 刘亦伟, 王长连, 黄品芳, 等. 1186例次癫痫患者丙戊酸钠血药浓度监测分析[J]. 中国医院药学杂志, 2010, 30(9): 775-777.
[17] 姜庆城. 癫痫患者体内不同丙戊酸钠血药浓度与疗效的关系[J].中国实用神经疾病杂志, 2015, 18(24): 79-80.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.